Market Overview

Sage Therapeutics (NASDAQ: SAGE)

153.46 -7.78 (-4.83%)

Earnings

QuarterPriorEstimateActualSurprise
Q1 2019
Pre-Market
EPS:
REV:
-1.68



Q4 2018
Pre-Market
EPS:
REV:
-1.75



Q3 2018
Pre-Market
EPS:
REV:
-1.97



Q2 2018
After-Hours
EPS:
REV:
-1.88



Q1 2018
Pre-Market
EPS:
REV:
-1.52
-1.84
-1.68
-8.7%
Q4 2017
Pre-Market
EPS:
REV:
-1.50
-1.99
-1.75
-12.06%
Q3 2017
Pre-Market
EPS:
REV:
-1.15
-1.97
-1.97

Q2 2017
After-Hours
EPS:
REV:
-1.08
-1.67
-1.88
12.57%
Q1 2017
After-Hours
EPS:
REV:
-0.97
-1.61
-1.52
-5.59%
Q4 2016
Pre-Market
EPS:
REV:
-0.99
-1.16
-1.50
29.31%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!